#USA #New York #NYU Langone #Alzheimer's Disease #Neutrophils

Uncovering the Link Between Neutrophils and Alzheimer's Disease

A groundbreaking study led by researchers at NYU Langone Health has revealed that higher numbers of neutrophils—key white blood cells in the immune system—may indicate an increased risk of developing Alzheimer's disease and other forms of dementia. This research illuminates the possibility of identifying patients at risk long before they show any signs of cognitive decline.

Neutrophils: The Body's First Responders

Neutrophils play a crucial role in the body’s immune response, typically increasing in number during infections or inflammatory conditions. The ratio of neutrophils to lymphocytes, known as the neutrophil to lymphocyte ratio (NLR), provides critical information about a person’s immune status and can be easily determined from standard blood tests.

In this study, the researchers analyzed NLR data from nearly 400,000 patients across two healthcare systems. Their findings indicate that elevated NLR could serve as a significant marker for predicting the rise of Alzheimer's and related dementia, particularly before any noticeable cognitive symptoms manifest.

Study Findings

Dr. Tianshe (Mark) He, a data scientist in the Department of Psychiatry at NYU Grossman School of Medicine, is the first author of the study. He states, “This is the first large-scale investigation to demonstrate an association between neutrophil metrics and dementia risk in humans.”

The research utilized the earliest NLR measurements of patients aged 55 and older, ensuring these readings occurred prior to any dementia diagnosis within the study's timeframe. The results revealed that an increased NLR corresponds significantly with both long-term and short-term risks for Alzheimer's disease.

Notably, the risk linked to elevated NLR values was particularly pronounced among Hispanic patients and women, indicating potential socio-genetic factors which warrant further investigation.

According to Dr. Jaime Ramos-Cejudo, co-senior author and assistant professor at NYU, while elevated NLR alone is insufficient for predicting dementia risk, it may be a valuable part of a broader risk assessment strategy to identify individuals who require more comprehensive evaluations and potential interventions.

Implications for Future Research

In support of this notion, neutrophil elevation may contribute actively to the disease progression itself. Despite their critical role in healing, neutrophils can also cause damaging inflammation, leading to issues observed in Alzheimer's pathology.

The authors underscore the pressing need to further understand the connection between neutrophil behavior and the development of cognitive decline. Dr. Ramos-Cejudo’s lab is currently investigating how neutrophil activity correlates with brain imaging techniques and cognitive assessments in patients suffering from Alzheimer's and dementia.

“Future studies will determine whether neutrophils are merely markers of the disease or if they are perpetrators of cognitive decline,” he explained. If they turn out to be a contributing factor, they could serve as a prime target for future Alzheimer therapies.

Conclusion

The study, which was published in the journal Alzheimer's & Dementia on April 3, marks a significant advance in our understanding of Alzheimer’s risk factors. Identifying elevated NLR not only paves the way for early diagnosis but also enhances the potential for early treatment interventions before cognitive symptoms emerge. Continued research in this area could revolutionize how we approach Alzheimer’s diagnosis and treatment globally.

The study was supported by multiple grants from the National Institutes of Health and other organizations, showcasing the collaborative effort to better understand this complex disease. As research continues, stakeholders hope that enhanced awareness and diagnostic measures can one day assist in combating the alarming rise of Alzheimer's disease prevalence in the aging population.